Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![seat11a_com Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1454385492313640961.png) seat11a - Gateway to In-Depth Financial Insights [@seat11a_com](/creator/twitter/seat11a_com) on x XXX followers
Created: 2025-07-18 11:10:50 UTC

Carl Zeiss Meditec China Deep Dive – Resilient Growth, Local Focus
Carl Zeiss Meditec has grown China into its #1 country market, contributing over a quarter of group revenues.

In this detailed investor presentation, Sebastian Frericks outlines:
✔ ZEISS’ strategic response to VBP and policy shifts
✔ The surge in premium IOLs and cataract procedures
✔ Continued market leadership in refractive surgery with the VISUMAX® XXX

With strong brand recognition, local manufacturing, and China-specific R&D, ZEISS is well-positioned to sustain long-term leadership.

📺 Watch the full deep dive on seat11a.


#MedicalDevices #HealthcareInvesting #ChinaStrategy #ZeissVision #Ophthalmology #seat11a $AFX
@ZEISSmeditec 

📲 Follow seat11a:
🔗 Website:
📢 LinkedIn:
🐦 Twitter:
🎧 Spotify:

T&C: 


![](https://pbs.twimg.com/amplify_video_thumb/1946165425102020608/img/kLF4T7iewtfNwLat.jpg)

XX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946165761128665253/c:line.svg)

**Related Topics**
[surge](/topic/surge)
[investment](/topic/investment)
[china](/topic/china)
[$afxde](/topic/$afxde)
[carl zeiss](/topic/carl-zeiss)

[Post Link](https://x.com/seat11a_com/status/1946165761128665253)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

seat11a_com Avatar seat11a - Gateway to In-Depth Financial Insights @seat11a_com on x XXX followers Created: 2025-07-18 11:10:50 UTC

Carl Zeiss Meditec China Deep Dive – Resilient Growth, Local Focus Carl Zeiss Meditec has grown China into its #1 country market, contributing over a quarter of group revenues.

In this detailed investor presentation, Sebastian Frericks outlines: ✔ ZEISS’ strategic response to VBP and policy shifts ✔ The surge in premium IOLs and cataract procedures ✔ Continued market leadership in refractive surgery with the VISUMAX® XXX

With strong brand recognition, local manufacturing, and China-specific R&D, ZEISS is well-positioned to sustain long-term leadership.

📺 Watch the full deep dive on seat11a.

#MedicalDevices #HealthcareInvesting #ChinaStrategy #ZeissVision #Ophthalmology #seat11a $AFX @ZEISSmeditec

📲 Follow seat11a: 🔗 Website: 📢 LinkedIn: 🐦 Twitter: 🎧 Spotify:

T&C:

XX engagements

Engagements Line Chart

Related Topics surge investment china $afxde carl zeiss

Post Link

post/tweet::1946165761128665253
/post/tweet::1946165761128665253